December 17th 2025

Beacon Hospital First in the World to Use Prism-2 Software with Medtronic Affera System

A Global First as Beacon Hospital first to use the new Prism-2 Software for Medtronic Affera System

 

Beacon Hospital is the first globally to use the newest version of Prism-2 software for the Affera Mapping and Ablation System by Medtronic. This marks another important milestone in advanced cardiac care at Beacon Hospital.

Prof Jonathan Lyne, Director of Cardiac Electrophysiology & Consultant Electrophysiologist, and our Cath Lab team were the first to use this pioneering software in a clinical setting.

Previously, Beacon Hospital was among the first five hospitals worldwide to adopt the Affera system and earlier this year became the first centre to complete 250 procedures using the system. The introduction of Prism-2 builds on this experience, enhancing procedural efficiency, clinical insight and future capabilities within the Cath Lab.

The Affera System is used to treat patients with Atrial Fibrillation (AF). Atrial Fibrillation (AF) is a serious condition that can lead to stroke, heart failure, and other cardiovascular complications. Approximately one in four people over the age of 50 are at risk of developing AF. AF is also linked to increased hospital admissions and may have a significant impact on quality of life.

Prism-2 introduces a number of software advancements designed to support more streamlined workflows. These include enhanced navigation capabilities that allow clinicians to visualise both sensor-based and non-sensor-based catheters during procedures, supporting accurate mapping and treatment delivery. The update also enables low- or zero-fluoroscopy workflows, helping to minimise radiation exposure for both patients and clinical teams.

Additional advancements in the Prism-2 software include simplified Cath Lab setup, with improved connectivity to recording systems, direct digital ECG signal acquisition and streamlined procedure preparation. Importantly, Prism-2 also provides the foundation for future developments on the Affera system. Together, these enhancements support efficiency for our clinical teams while maintaining the highest standards of patient care.

This global first reflects the ongoing collaboration between Beacon Hospital’s clinical, technical and operational teams and the hospital’s continued commitment to investing in advanced technologies that support patient-focused care.

 

Prism-2 Software for Medtronic Affera System. Beacon Hospital is a global leader in this Cath Lab technology.